ZA200906539B - 4-(Pyrrolopyridinyl)pyrimidin-2-Ylamine Derivatives - Google Patents

4-(Pyrrolopyridinyl)pyrimidin-2-Ylamine Derivatives

Info

Publication number
ZA200906539B
ZA200906539B ZA200906539A ZA200906539A ZA200906539B ZA 200906539 B ZA200906539 B ZA 200906539B ZA 200906539 A ZA200906539 A ZA 200906539A ZA 200906539 A ZA200906539 A ZA 200906539A ZA 200906539 B ZA200906539 B ZA 200906539B
Authority
ZA
South Africa
Prior art keywords
pyrrolopyridinyl
pyrimidin
ylamine derivatives
ylamine
derivatives
Prior art date
Application number
ZA200906539A
Other languages
English (en)
Inventor
Dieter Dorsch
Christian Sirrenberg
Thomas J J Mueller
Eugen Merkul
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA200906539B publication Critical patent/ZA200906539B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200906539A 2007-02-21 2009-09-18 4-(Pyrrolopyridinyl)pyrimidin-2-Ylamine Derivatives ZA200906539B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102007008419A DE102007008419A1 (de) 2007-02-21 2007-02-21 4-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate

Publications (1)

Publication Number Publication Date
ZA200906539B true ZA200906539B (en) 2010-06-30

Family

ID=39410261

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200906539A ZA200906539B (en) 2007-02-21 2009-09-18 4-(Pyrrolopyridinyl)pyrimidin-2-Ylamine Derivatives

Country Status (18)

Country Link
US (2) US8293891B2 (enExample)
EP (1) EP2121682B1 (enExample)
JP (1) JP5508026B2 (enExample)
KR (1) KR20090110948A (enExample)
CN (1) CN101616918A (enExample)
AR (1) AR065390A1 (enExample)
AU (1) AU2008217297B2 (enExample)
BR (1) BRPI0808167A2 (enExample)
CA (1) CA2678691C (enExample)
DE (1) DE102007008419A1 (enExample)
DK (1) DK2121682T3 (enExample)
EA (1) EA200901100A1 (enExample)
ES (1) ES2427594T3 (enExample)
IL (1) IL200470A (enExample)
MX (1) MX2009008864A (enExample)
PT (1) PT2121682E (enExample)
WO (1) WO2008101587A1 (enExample)
ZA (1) ZA200906539B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2026654A4 (en) * 2006-05-26 2013-07-17 Univ Louisville Res Found MACROPHAGE MIGRATION HEMMFAKTOR ANTAGONISTS AND USE METHOD THEREFOR
US9162987B2 (en) 2009-09-24 2015-10-20 University Of Louisville Research Foundation, Inc. Iodo pyrimidine derivatives useful for the treatment of macrophage migration inhibitory factor (MIF)-implicated diseases and conditions
US9155790B2 (en) 2010-05-20 2015-10-13 University of Lousiville Research Foundation, Inc. Methods and compositions for modulating ocular damage

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747469A (en) 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
GB9904387D0 (en) 1999-02-25 1999-04-21 Pharmacia & Upjohn Spa Antitumour synergistic composition
RU2292904C2 (ru) * 2001-01-09 2007-02-10 Мерк Патент Гмбх Комбинированная терапия, использующая ингибиторы рецептора тирозинкиназы и ингибиторы ангиогенезиса
GB0308466D0 (en) 2003-04-11 2003-05-21 Novartis Ag Organic compounds
WO2006038001A1 (en) * 2004-10-06 2006-04-13 Celltech R & D Limited Aminopyrimidine derivatives as jnk inhibitors

Also Published As

Publication number Publication date
PT2121682E (pt) 2013-10-17
WO2008101587A1 (de) 2008-08-28
BRPI0808167A2 (pt) 2014-07-08
MX2009008864A (es) 2009-08-28
US8293891B2 (en) 2012-10-23
ES2427594T3 (es) 2013-10-31
JP2010519230A (ja) 2010-06-03
AU2008217297A1 (en) 2008-08-28
DE102007008419A1 (de) 2008-08-28
CA2678691A1 (en) 2008-08-28
US20120264999A1 (en) 2012-10-18
DK2121682T3 (da) 2013-09-08
EP2121682B1 (de) 2013-07-10
IL200470A0 (en) 2010-04-29
JP5508026B2 (ja) 2014-05-28
AR065390A1 (es) 2009-06-03
EA200901100A1 (ru) 2010-02-26
US8557977B2 (en) 2013-10-15
US20110092527A1 (en) 2011-04-21
KR20090110948A (ko) 2009-10-23
EP2121682A1 (de) 2009-11-25
CA2678691C (en) 2015-09-08
IL200470A (en) 2014-02-27
AU2008217297B2 (en) 2013-01-17
CN101616918A (zh) 2009-12-30

Similar Documents

Publication Publication Date Title
ZA201003875B (en) Novel pyrimidine derivatives
IL210176A0 (en) Substituted pyrimidone derivatives
IL205759A0 (en) Isoxazolo-pyridine derivatives
IL205753A0 (en) Isoxazolo-pyridazine derivatives
IL202020A0 (en) Spiroindolinone derivatives
PT2154967E (pt) Derivados de pirimidina
ZA201006104B (en) Substituted xanthine derivatives
ZA201001058B (en) Quinazolinamide derivatives
ZA201000431B (en) Indazolamide derivatives
IL205755A0 (en) Isoxazolo-pyrazine derivatives
IL200618A0 (en) Aza-pyridopyrimidinone derivatives
IL201446A0 (en) Heteroarylamide pyrimidone compounds
IL210613A0 (en) Novel acylaminobenzamide derivatives
ZA201005382B (en) Substituted heteroarylamide diazepinopyrimidone derivatives
IL202667A0 (en) Isoxazole-imidazole derivatives
ZA201005381B (en) Substituted heteroarylamide oxazepinopyrimidone derivatives
EP2141168A4 (en) HETEROARYLATED DERIVATIVES
PL2245028T3 (pl) Pochodne 5-aminocyklilometyloksazolidyn-2-onu
EP2133347A4 (en) 1-BIARYLAZETIDINONDERIVATE
IL202463A0 (en) Sulfonyl-quinoline derivatives
IL202159A0 (en) Piperidine-amide derivatives
ZA200906539B (en) 4-(Pyrrolopyridinyl)pyrimidin-2-Ylamine Derivatives
ZA201002218B (en) Thiadiazinone derivatives
AP2009005065A0 (en) Sulfonyl-quinoline derivatives
ZA201000311B (en) Sulfonyl-quinoline derivatives